These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31477157)

  • 21. Separate and Combined Glucometabolic Effects of Endogenous Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide 1 in Healthy Individuals.
    Gasbjerg LS; Helsted MM; Hartmann B; Jensen MH; Gabe MBN; Sparre-Ulrich AH; Veedfald S; Stensen S; Lanng AR; Bergmann NC; Christensen MB; Vilsbøll T; Holst JJ; Rosenkilde MM; Knop FK
    Diabetes; 2019 May; 68(5):906-917. PubMed ID: 30626611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of fat supplementation on postprandial GIP, GLP-1, ghrelin and IGFBP-1 levels: a pilot study on adolescents with type 1 diabetes.
    Lodefalk M; Carlsson-Skwirut C; Holst JJ; Aman J; Bang P
    Horm Res Paediatr; 2010; 73(5):355-62. PubMed ID: 20389106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study.
    Bergmann NC; Lund A; Gasbjerg LS; Meessen ECE; Andersen MM; Bergmann S; Hartmann B; Holst JJ; Jessen L; Christensen MB; Vilsbøll T; Knop FK
    Diabetologia; 2019 Apr; 62(4):665-675. PubMed ID: 30683945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus.
    Aaboe K; Knop FK; Vilsbøll T; Deacon CF; Holst JJ; Madsbad S; Krarup T
    Diabetes Obes Metab; 2010 Apr; 12(4):323-33. PubMed ID: 20380653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis.
    Edholm T; Degerblad M; Grybäck P; Hilsted L; Holst JJ; Jacobsson H; Efendic S; Schmidt PT; Hellström PM
    Neurogastroenterol Motil; 2010 Nov; 22(11):1191-200, e315. PubMed ID: 20584260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction.
    Verdich C; Toubro S; Buemann B; Lysgård Madsen J; Juul Holst J; Astrup A
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1206-14. PubMed ID: 11477506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mixed Meal and Intravenous L-Arginine Tests Both Stimulate Incretin Release Across Glucose Tolerance in Man: Lack of Correlation with β Cell Function.
    Ruetten H; Gebauer M; Raymond RH; Calle RA; Cobelli C; Ghosh A; Robertson RP; Shankar SS; Staten MA; Stefanovski D; Vella A; Wright K; Fryburg DA;
    Metab Syndr Relat Disord; 2018 Oct; 16(8):406-415. PubMed ID: 30117761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of a traditional breakfast leads to increased satiety along with attenuated plasma increments of glucose, C-peptide, insulin, and glucose-dependent insulinotropic polypeptide in humans.
    Ohlsson B; Höglund P; Roth B; Darwiche G
    Nutr Res; 2016 Apr; 36(4):359-368. PubMed ID: 27001281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects.
    Thomsen C; Rasmussen O; Lousen T; Holst JJ; Fenselau S; Schrezenmeir J; Hermansen K
    Am J Clin Nutr; 1999 Jun; 69(6):1135-43. PubMed ID: 10357731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of fat on gastric emptying of and the glycemic, insulin, and incretin responses to a carbohydrate meal in type 2 diabetes.
    Gentilcore D; Chaikomin R; Jones KL; Russo A; Feinle-Bisset C; Wishart JM; Rayner CK; Horowitz M
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2062-7. PubMed ID: 16537685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mixed meal ingestion diminishes glucose excursion in comparison with glucose ingestion via several adaptive mechanisms in people with and without type 2 diabetes.
    Alsalim W; Tura A; Pacini G; Omar B; Bizzotto R; Mari A; Ahrén B
    Diabetes Obes Metab; 2016 Jan; 18(1):24-33. PubMed ID: 26354383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postprandial hormone and metabolic responses in simulated shift work.
    Hampton SM; Morgan LM; Lawrence N; Anastasiadou T; Norris F; Deacon S; Ribeiro D; Arendt J
    J Endocrinol; 1996 Nov; 151(2):259-67. PubMed ID: 8958786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of action of pre-meal consumption of whey protein on glycemic control in young adults.
    Akhavan T; Luhovyy BL; Panahi S; Kubant R; Brown PH; Anderson GH
    J Nutr Biochem; 2014 Jan; 25(1):36-43. PubMed ID: 24314863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A walnut-containing meal had similar effects on early satiety, CCK, and PYY, but attenuated the postprandial GLP-1 and insulin response compared to a nut-free control meal.
    Rock CL; Flatt SW; Barkai HS; Pakiz B; Heath DD
    Appetite; 2017 Oct; 117():51-57. PubMed ID: 28610906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics.
    Lee A; Patrick P; Wishart J; Horowitz M; Morley JE
    Diabetes Obes Metab; 2002 Sep; 4(5):329-35. PubMed ID: 12190996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
    Svane MS; Bojsen-Møller KN; Nielsen S; Jørgensen NB; Dirksen C; Bendtsen F; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E505-14. PubMed ID: 26786780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A supplementary infusion of glucose-dependent insulinotropic polypeptide (GIP) with a meal does not significantly improve the beta cell response or glucose tolerance in type 2 diabetes mellitus.
    Jones IR; Owens DR; Vora J; Luzio SD; Hayes TM
    Diabetes Res Clin Pract; 1989 Nov; 7(4):263-9. PubMed ID: 2693029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution.
    Knop FK; Vilsbøll T; Larsen S; Højberg PV; Vølund A; Madsbad S; Holst JJ; Krarup T
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E324-30. PubMed ID: 16954337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of different dietary loads on glucose-dependent insulinotropic polypeptide in subjects with normal glucose tolerance].
    Chen Z; Yan L; Fu XY; Yang HZ; Kuang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):2031-4. PubMed ID: 22200706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.